Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-05-17

Clinical Trial Update: A Study to Investigate the Safety of the Drugs Topiramate and Levetiracetam in Treating Children Recently Diagnosed With Epilepsy [Phase 3]

View source ↗

Summary

This Phase 3 trial update reports on the safety of topiramate and levetiracetam for children newly diagnosed with epilepsy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Keppra (levetiracetam)
  • Topamax (Topiramate)

Snippet

Sponsor: Janssen Research & Development, LLC | Conditions: Epilepsy | Phase 3 | Status: COMPLETED | Results posted: 2021-05-17